Antibodies to opacity proteins (Opa) correlate with a reduced risk of gonococcal salpingitis.
Open Access
- 1 April 1994
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 93 (4) , 1748-1755
- https://doi.org/10.1172/jci117159
Abstract
Acute salpingitis complicating cervical gonococcal infection is a significant cause of infertility. Relatively little data are available concerning the pathophysiologic mechanisms of this disease. A cohort of 243 prostitutes residing in Nairobi were followed between March 1985 and April 1988. Gonococcal cultures were performed at each visit, and acute salpingitis was diagnosed clinically. Serum at enrollment was tested by immunoblot for antibody to gonococcal outer membrane proteins. 8.6% (146/1689) of gonococcal infections were complicated by salpingitis. Increased risk of salpingitis was associated with younger age, shorter duration of prostitution, HIV infection, number of gonococcal infections, and episodes of nongonococcal salpingitis. Rmp antibody increased the risk of salpingitis. Antibody to Opa decreased the risk of salpingitis. By logistic regression analysis, antibody to Opa was independently associated with decreased risk of gonococcal salpingitis (adjusted odds ratio [OR], 0.35; 95% confidence interval [95%CI], 0.17-0.76); HIV infection (adjusted OR, 3.5; 95% CI, 0.96-12.8) and episodes of nongonococcal salpingitis (adjusted OR, 3.4; 95% CI, 1.8-6.4) were independently associated with an increased risk of salpingitis. Antibody to Opa appears to protect against ascending gonococcal infection, perhaps by interfering with Opa mediated adherence and endocytosis. The demonstration of natural immunity that protects against upper genital tract infection in women suggests that a vaccine to prevent gonococcal salpingitis is possible.Keywords
This publication has 31 references indexed in Scilit:
- Antibody to Rmp (outer membrane protein 3) increases susceptibility to gonococcal infection.Journal of Clinical Investigation, 1993
- Prevalence of gene sequences coding for hypervariable regions of Opa (protein II) in Neisseria gonorrhoeaeMolecular Microbiology, 1991
- In situ expression and localization of Neisseria gonorrhoeae opacity proteins in infected epithelial cells: apparent role of Opa proteins in cellular invasion.The Journal of Experimental Medicine, 1991
- Epidemiologic evidence for the development of serovar-specific immunity after gonococcal infection.Journal of Clinical Investigation, 1989
- Expression of outer membrane protein II by gonococci in experimental gonorrhea.The Journal of Experimental Medicine, 1988
- The Effect of Protein II and Pili on the Interaction of Neisseria gonorrhoeae with Human Polymorphonuclear LeucocytesMicrobiology, 1986
- Antigenic Variation During Infection with Neisseria gonorrhoeae: Detection of Antibodies to Surface Proteins in Sera of Patients with GonorrheaThe Journal of Infectious Diseases, 1984
- Variations in Surface Protein Composition Associated with Virulence Properties in Opacity Types of Neisseria gonorrhoeaeJournal of General Microbiology, 1979
- Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.Proceedings of the National Academy of Sciences, 1979
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970